A simple and robust LC-MS/MS method for measuring sirolimus and everolimus in whole blood

被引:13
|
作者
Yuan, Chao [1 ]
Payto, Drew [1 ]
Gabler, Jessica [2 ]
Wang, Sihe [1 ]
机构
[1] Cleveland Clin, Dept Clin Pathol, Cleveland, OH 44195 USA
[2] Thermo Fisher Sci, W Palm Beach, FL 33407 USA
关键词
TANDEM MASS-SPECTROMETRY; KIDNEY-TRANSPLANT PATIENTS; INTERNAL STANDARD; CYCLOSPORINE-A; LC/ESI-MS/MS; SDZ RAD; RAPAMYCIN; PHARMACOKINETICS; QUANTIFICATION; IDENTIFICATION;
D O I
10.4155/bio.14.43
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Therapeutic drug monitoring of immunosuppressants sirolimus and everolimus is mandatory and liquid chromatography tandem mass spectrometry (LC-MS/MS) is the preferred technology for the measurement. Due to the high hydrophobicity these analytes bind to reverse-phase columns tightly and need column heating to elute. Column heating not only requires extra instrument preparation but also causes permanent column damage if the heater is left on while elution pumps stop by the end of the run. The primary improvement in the current method was to elute the analytes at room temperature using special buffers. This new LC-MS/MS method has been validated for clinical use and offers improved simplicity and robustness by eliminating column heating yet with high sensitivity, precision and accuracy.
引用
收藏
页码:1597 / 1604
页数:8
相关论文
共 50 条
  • [1] A Direct Method for the Measurement of Everolimus and Sirolimus in Whole Blood by LC-MS/MS Using an Isotopic Everolimus Internal Standard
    Morgan, Phillip E.
    Brown, Nigel W.
    Tredger, J. Michael
    THERAPEUTIC DRUG MONITORING, 2014, 36 (03) : 358 - 365
  • [2] LC-MS/MS method for simultaneous quantification of Everolimus and Sirolimus
    Tancre, A. -S.
    Capron, A.
    Wallemacq, P.
    IMMUNO-ANALYSE & BIOLOGIE SPECIALISEE, 2012, 27 (06): : 345 - 351
  • [3] Robust, High-Throughput LC-MS/MS Method for Therapeutic Drug Monitoring of Cyclosporine, Tacrolimus, Everolimus, and Sirolimus in Whole Blood
    Koster, Reinco A.
    Dijkers, Eli C. F.
    Uges, Donald R. A.
    THERAPEUTIC DRUG MONITORING, 2009, 31 (01) : 116 - 125
  • [4] LC-MS/MS method for quantitative analysis of Tacrolimus, Sirolimus, Everolimus and Cyclosporin a in whole blood using TurboFlow technology
    Kozak, M.
    CLINICAL CHEMISTRY, 2008, 54 (06) : A12 - A12
  • [5] Simultaneous Determination of Cyclosporine A, Tacrolimus, Sirolimus, and Everolimus in Whole-Blood Samples by LC-MS/MS
    Karapirli, Mustafa
    Kizilgun, Murat
    Yesilyurt, Ozgur
    Gul, Husamettin
    Kunak, Zeki Ilker
    Akgul, Emin Ozgur
    Macit, Enis
    Cayci, Tuncer
    Kurt, Yasemin Gulcan
    Aydin, Ibrahim
    Yaren, Hakan
    Seyrek, Melik
    Cakir, Erdinc
    Yaman, Halil
    SCIENTIFIC WORLD JOURNAL, 2012,
  • [6] An isotope dilution LC-MS/MS based candidate reference method for the quantification of cyclosporine A, tacrolimus, sirolimus and everolimus in human whole blood
    Taibon, Judith
    van Rooij, Milou
    Schmid, Rupert
    Singh, Neeraj
    Albrecht, Eva
    Wright, Jo Anne
    Geletneky, Christian
    Schuster, Carina
    Moerlein, Sophie
    Vogeser, Michael
    Seger, Christoph
    Pongratz, Stephan
    Kobold, Uwe
    CLINICAL BIOCHEMISTRY, 2020, 82 : 73 - 84
  • [7] High-throughput LC-MS/MS analysis of sirolimus in whole blood
    Wallemacq, P
    Vanbinst, R
    Asta, S
    Cooper, D
    THERAPEUTIC DRUG MONITORING, 2003, 25 (04) : 534 - 534
  • [8] Development of a Novel and Rapid LC-MS/MS Method for Measuring Phosphatidylethanol in Whole Blood
    Nielsen, Jacob
    Yang, Qingwen
    Lahorewala, Sarrah
    Yi, Xin
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2024, 162 : S171 - S171
  • [9] Sensitive quantification of sirolimus and everolimus by LC-MS/MS with online sample cleanup
    Mueller, Daniel M.
    Rentsch, Katharina M.
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2010, 878 (13-14): : 1007 - 1012
  • [10] Comparison of two rapid LC-MS/MS procedures for analysis of sirolimus in whole blood.
    Nelson, GJ
    Kushnir, MM
    Rockwood, AL
    Urry, FM
    CLINICAL CHEMISTRY, 2002, 48 (06) : A45 - A46